INTRAVASCULAR PLATELET ACTIVATION IN WOMEN WITH MISSION OF PREGNANCY WITH AND WITHOUT HYPERHOMOCYSTEINEMIA
DOI:
https://doi.org/10.5281/zenodo.8213511Abstract
Miscarriage is currently defined as the recurring cessation of pregnancy. There are many syndromes associated with recurrent miscarriage: anatomical abnormalities, hormonal disorders, chromosomal defects, disorders in the state of the blood coagulation system.
References
Andrianova M. Yu., Roitman E. V., Isaeva A. M., Kolesnikova I. M., Nureev M. V. Pathogenetic and clinical substantiation of the complex prevention of hyperhomocysteinemia // Archives of Internal Medicine. 2014. No. 4.-С 51-56
Baranova, E.I. Clinical significance of homocysteinemia (literature review) / E.I. Baranova, O.O. Bolshakova // Arterial hypertension. - 2004. - T. 10, No. 1. - S. 12-18.
Butenko A. V. Homocysteine: influence on biochemical processes in the human body // Young scientist. - 2016. - No. 1. — S. 78-82.
Genetic disorders of the coagulation cascade and homocysteine metabolism in the genesis of cerebral thrombosis / O. V. Sirotkina, Yu. V. Cherkas, A. V. Merkulova et al. // Med. academic journal. 2004. -T. 4, No. 4. - S. 23-28.
Kanevskaya, N.P. Platelet-vascular system of hemostasis in metabolic disorders in women with arterial hypertension: Abstract of the thesis. dis. . cand. honey. Sciences. - Orenburg, 2003. - 24 p.
Kozlova, T.V. Hyperhomocysteinemia as a clinical manifestation of the risk of thrombosis / T.V. Kozlova // Wedge, medicine. 2005. - No. 2. - S. 9-11.
Clinical aspects of hypercysteinemia: monograph / ed. V.A. Snezhitsky, V.M. Pyrochkina [i dr.]. - GrGMU, 2011. - 292 p.
Makarenko, M.V. Management of pregnant women with fetal growth retardation syndrome on the background of thrombophilia and hyperhomocysteinemia / M.V. Makarenko // Family medicine. - 2014. - No. 3 (53). - S. 155.
Naumov, A.V. Homocysteine in the pathogenesis of microcirculatory and thrombotic complications / A.V. Naumov, T.N. Grinevich, V.M. Naidina // Thrombosis, hemostasis and rheology. - 2012. - T. 49, No. 4 - S. 9-19.
The level of homocysteine and indicators of platelet aggregation in patients with impaired cerebral circulation / Z. Sabaliauskiene, P. Gribauskas, V. Gaigalaite [et al.] // Therapeutic archive. - 2013. - T. 85, No. 3. - S. 75-79.
Shilova, A.N. Thromboembolism of the pulmonary arteries against the background of hyperhomocysteinemia / A.N. Shilova, A.A. Karpenko, Yu.E. Klevanets // Angiology and vascular surgery. - 2015. - V. 21, No. 1. - S. 25-28.
Shevchenko, O.P. Homocysteine is a new risk factor for atherosclerosis and thrombosis / O.P. Shevchenko // Klin. lab. diagnostics. - 2004. - No. 10. - S. 25-31.
Shitikova, A.S. Method for determining intravascular platelet activation and its significance in clinical practice / A.S. Shitikova, L.R. Tarkovskaya, V.D. Kargin // Klin. lab. diagnostics. 1997. - No. 2. - S. 23-25.
Perla-Kajan J., Twardowski1 T., and Jakubowski H. Mechanisms of homocysteine toxicity in humans // Amino Acids (2007) 32: 561–572
Yilmaz N. Relationship between paraoxonase and homocysteine: crossroads of oxidative diseases // Arch Med Sci 1, February / 2012. P. 138–153.
